8-K

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): April 27, 1999

                                  CAPRIUS, INC.
                                  -------------

             (Exact name of registrant as specified in its charter)

Delaware                             0-11914                          22-2457487
- --------                             -------                          ----------

(State or other jurisdiction       (Commission                     (IRS Employer
of incorporation)                  File Number)              Identification No.)


                46 Jonspin Road, Wilmington, Massachusetts 01887
                ------------------------------------------------

               (Address of principal executive offices) (Zip Code)

Registrant's Telephone Number including Area Code:  (978) 657-8876







Item 5.  Other Events

On April 28, 1999, Caprius, Inc. (the "Registrant") announced that it had
concluded the sale of its Aurora(R) breast scanner technology related assets to
Pacific Republic Capital Corp ("Pacific") for approximately $850,000 in cash and
the assumption by Pacific of certain obligations associated with the transferred
assets.

The Registrant further announced that the settlement of the shareholders class
action, which was commenced in January 1998, was given final court approval in
Federal Court in Boston.

A copy of the Press Release issued by the Registrant is attached hereto as
Exhibit 99.1 and incorporated herein by reference.

Item 7.  Financial Statements and Exhibits

(c)      Exhibits:
         The following exhibit is filed as part of this report:

         99.1     Press Release, dated April 28, 1999 issued by Caprius, Inc.




                                       -2-



                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                              CAPRIUS, INC.

Dated:  May 4, 1999                           By:      /s/ Enrique Levy
                                                       ----------------
                                                       Name:   Enrique Levy
                                                       Title:  President




                                       -3-





                                  EXHIBIT INDEX
                                  -------------



The following Exhibit is filed herewith.


                                                      Sequentially
Exhibit                                               Numbered
Number        Description                             Page
- ------        -----------                             ----

99.1          Press Release issued by Caprius,               5
              Inc., dated April 28, 1999.







                                       -4-

EX-99.1

                                                                    Exhibit 99.1

[GRAPHIC OMITTED]

FOR IMMEDIATE RELEASE



Contact:    Beverly Tkaczenko
            @ 800.476.0569

CAPRIUS ANNOUNCES SALE OF ITS TECHNOLOGY ASSETS

Fort Lee, NJ - April 28, 1999 - Caprius,  Inc.  (Nasdaq:  CAPR)  announced today
that it had concluded a sale of all of its Aurora(R)  breast scanner  technology
related assets. The Company sold the assets to Pacific Republic Capital Corp. of
California.  The terms of the  transaction  provide  for  payment  to Caprius of
approximately  $850,000  and  the  assumption  by  the  buyer  of all  the  debt
associated with this technology as well as the lease at the Company's Wilmington
facility.  The  equipment  debt of which  Caprius is now  relieved  exceeds $1.1
million.

Under  the  terms  of  the   contract,   Caprius   will   transfer  all  of  its
technology-related  assets including the Aurora(R) Centers at Faulkner Hospital,
Englewood  Hospital  and Medical  Center,  University  of  Arkansas  for Medical
Sciences,  and  Magee  Women's  Hospital.  Caprius  has also  sold  the  related
inventory and fixed assets. The buyer shall retain the current employees.

Caprius has over the past year been  attempting to identify a financial  partner
for its  technology.  Caprius  conducted  discussions  with  numerous  potential
parties,  none of which led to an acceptable proposal.  The cash reserves of the
Company,  after several downsizing events that were started more than six months
ago,  had  dwindled  to  near  depletion  at  the  time  of  this  closing.  The
consummation of this transaction  avoided the imminent  necessity of closing the
technology  activities without relief from the associated debt. The buyer at the
time of closing  was the only party with the  capacity  and desire to assume the
debt and compensate Caprius on an immediate basis.

Caprius intends to aggressively pursue ways that can maximize shareholder value.
The Company  currently has dramatically  reduced its overhead,  provided for the
extinguishment  of its  debt,  and is left  with  limited  funds  and the  Strax
Institute, a comprehensive breast-imaging center in Lauderhill, Florida. Caprius
shall focus its efforts in identifying,  as quickly as possible, a candidate who
can help  utilize  the  Company's  assets as a vehicle  for the  enhancement  of
shareholder value.

Caprius further  announced that the settlement of the shareholders  class action
commenced  in January 1998  obtained  final court  approval in Federal  Court in
Boston.

SAFE HARBOR STATEMENT:

The  statements  made in this press  release  that are not  historical  fact are
"forward-looking  statements"  which are based upon  current  expectations  that
include a number of risks and uncertainties.  Investors are encouraged to review
a more comprehensive listing of cautionary statements and risk factors contained
in the Company's Forms 10-K and 10-Q SEC filings.

                                       ###



                                       -5-